Serial Measurements of Mesothelioma Serum Biomarkers in Asbestos-Exposed Individuals: A Prospective Longitudinal Cohort Study
Open Access
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 6 (5) , 889-895
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant MesotheliomaCancer Epidemiology, Biomarkers & Prevention, 2010
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesotheliomaEuropean Respiratory Journal, 2009
- Glomerular Filtration Rate Is a Confounder for the Measurement of Soluble Mesothelin in SerumClinical Chemistry, 2009
- Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Nonmalignant Asbestos-Related Pleural Disease: Relation with Past Asbestos ExposureCancer Epidemiology, Biomarkers & Prevention, 2009
- Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelinLung Cancer, 2008
- Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case–control studyLung Cancer, 2008
- Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung CancerClinical Cancer Research, 2007
- MESOMARK™: A Potential Test for Malignant Pleural MesotheliomaClinical Chemistry, 2007
- Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian CancerClinical Cancer Research, 2006
- MesothelinClinical Cancer Research, 2004